| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 20 |
| 1 | METHOTREXATE | 18 |
| 2 | ETOPOSIDE | 14 |
| 3 | DENOSUMAB | 12 |
| 4 | PREDNISONE | 12 |
| 5 | DEXAMETHASONE | 11 |
| 6 | DEXAMETHASONE 1.5 MG | 11 |
| 7 | ALENDRONATE SODIUM | 10 |
| 8 | CYCLOPHOSPHAMIDE | 9 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLUORIDE TOOTHPASTE | 1 | 0.0050 |
| 1 | EUCALYPTOL, MENTHOL, UNSPECIFIED FORM, METHYL SALICYLATE, AND THYMOL | 1 | 0.0045 |
| 2 | IDARUBICIN HYDROCHLORIDE | 1 | 0.0009 |
| 3 | HYALURONIC ACID | 1 | 0.0009 |
| 4 | TALQUETAMAB-TGVS | 1 | 0.0007 |
| 5 | BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B | 1 | 0.0006 |
| 6 | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | 1 | 0.0006 |
| 7 | PAMIDRONATE DISODIUM | 2 | 0.0006 |
| 8 | BACITRACIN | 2 | 0.0005 |
| 9 | METHIMAZOLE | 4 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 27 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 18 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 16 |
| 3 | Topoisomerase Inhibitor [EPC] | 14 |
| 4 | Alkylating Drug [EPC] | 13 |
| 5 | Benzodiazepine [EPC] | 13 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 13 |
| 7 | Aromatase Inhibitor [EPC] | 12 |
| 8 | RANK Ligand Inhibitor [EPC] | 12 |
| 9 | Kinase Inhibitor [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thyroid Hormone Synthesis Inhibitor [EPC] | 4 | 0.0004 |
| 1 | Neuraminidase Inhibitor [EPC] | 1 | 0.0004 |
| 2 | Lipid-based Polyene Antifungal [EPC] | 3 | 0.0002 |
| 3 | Topoisomerase Inhibitor [EPC] | 14 | 0.0002 |
| 4 | Asparagine-specific Enzyme [EPC] | 2 | 0.0001 |
| 5 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 6 | Polyene Antifungal [EPC] | 5 | 0.0001 |
| 7 | Estrogen Receptor Antagonist [EPC] | 5 | 0.0001 |
| 8 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 9 | Aromatase Inhibitor [EPC] | 12 | 0.0001 |